What was reported
CRISPRLungo analyzes long-read amplicon data to distinguish edited alleles and structural outcomes such as larger deletions and inversions. The author-lab description includes error correction, statistical filtering and a browser application. [C07]
What the result does not establish
A targeted amplicon assay does not establish that the whole genome is free of unintended changes. Karam has not independently validated this pipeline or adopted it as a commercial service.
Measured endpoint
Allele classification, small sequence changes and structural outcomes within the assayed region.
Karam’s next question
Which outcome classes, controls, assay blind spots and software version should be required before interpreting a dataset?
Assessment-derived brief. Author-laboratory publication abstract, repository and browser-tool page located on 15 October 2026; no independent software performance test. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.
